Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 18, No 2 (2022) The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects Abstract  similar documents
N. B. Lebedeva, L. Yu. Chesnokova
"... Цель настоящего обзора – осветить современные аспекты применения левосимендана как последнего ..."
 
Vol 14, No 2 (2018) IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE Abstract  similar documents
M. V. Lediakhova, S. N. Nasonova, I. V. Zhirov, M. V. Andreevskaya, R. M. Bogieva, T. M. Uskach, M. A. Saidova, V. P. Masenko, S. N. Tereshchenko
"... Актуальность. Инфузия левосимендана может быть использована при лечении пациентов с острой ..."
 
Vol 4, No 1 (2008) OPTIMIZATION OF THE TREATMENT OF ELDERLY PATIENTS WITH MYOCARDIAL INFARCTION BY REVASCULARIZATION IN COMBINATION WITH INOTROPIC STIMULATION AND MYOCARDIAL UNLOADING Abstract  similar documents
D. S. Krivonosov, L. Yu. Chesnokova, N. I. Tarasov
"... стимуляции левосименданом (ЛС); 20 больных, у которых ограничились эндоваскулярной реваскуляризацией миокарда ..."
 
Vol 14, No 4 (2018) New Clinical Aspects of Eplerenone Use in Clinical Practice Abstract  similar documents
S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina
"... of mineralocorticoid receptor antagonists in patients with heart failure with reduced left ventricular ejection ..."
 
Vol 7, No 4 (2011) THE STICH TRIAL — THE IMPORTANCE OF DRUGS IN PATIENTS WITH CORONARY ARTERY DISEASE WAS HIGHER THAN EXPECTED Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko
"... Приводятся основные результаты исследования STICH (Surgical Treatment for Ischemic Heart Failure ..."
 
Vol 8, No 2 (2012) THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
"... different mechanisms of action, is presented in patients with chronic heart failure (CHF) on the base ..."
 
Vol 8, No 1 (2012) URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL  similar documents
S. von Haehling, J. C. Schefold, E. A. Jankowska, J. Springer, A. Vazir, P. R. Kalra, A. Sandek, G. Fauler, T. Stojakovic, M. Trauner, P. Ponikowski, H-D. Volk, W. Doehner, A. J. S. Coats, P. A. Poole-Wilson, S. D. Anker
 
Vol 22, No 3 (2026) Comparison of the furosemide dose titration in the first day of treatment for decompensated chronic heart failure using urine output or urine sodium concentration monitoring Abstract  similar documents
Ch. N. Sharapudinova, I. S. Yavelov, V. I. Vechоrko, O. V. Averkov, A. S. Samorukova, M. V. Yarygina, T. V. Duduk, O. M. Drapkina
"... декомпенсации хронической сердечной недостаточности (ХСН) с задержкой жидкости с помощью контроля объёма ..."
 
Vol 17, No 3 (2021) Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches Abstract  similar documents
A. A. Shchendrygina, K. A. Zhbanov, E. V. Privalova, A. O. Yusupova, Yu. A. Danilogorskaya, E. Yu. Salakheeva, I. Ya. Sokolova, S. A. Tsatsurova, A. A. Ageeva, Yu. N. Belenkov
"... Хроническая сердечная недостаточность с сохраненной фракцией выброса (СНсФВ) характеризуется ..."
 
Vol 3, No 1 (2007) RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY Abstract  similar documents
M. L. Maximov
"... недостаточности (ХСН) и собственные данные по изучению эффективности и переносимости небиволола у 113 больных ..."
 
Vol 3, No 5 (2007) LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE Abstract  similar documents
N. P. Kutishenko, S. J. Martsevich
"... Data of multicenter clinical trials on assessment of angiotensin converting enzyme inhibitor ..."
 
Vol 12, No 5 (2016) Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure Abstract  similar documents
A. A. Petrukhina, S. N. Tereshchenko, I. V. Zhirov
"... The review analyzes new treatment for patients with chronic heart failure (CHF) with low ejection ..."
 
Vol 19, No 6 (2023) Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible? Abstract  similar documents
V. D. Zakiev, N. M. Vorobyeva, I. P. Malaya, A. D. Gvozdeva, O. N. Tkacheva
"... Хроническая сердечная недостаточность (ХСН) — сложный клинический синдром, характеризующийся ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... Хроническая сердечная недостаточность (ХСН) представляет собой значимую социальную и экономическую ..."
 
Vol 8, No 1 (2012) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... . Efficacy of ω-3 PUFA was confirmed by results of the large-scale clinical trials. Data on ω-3 PUFA efficacy ..."
 
Vol 16, No 3 (2020) Dynamics of Vascular Stiffness and Endothelial Function in Combination Therapy of Heart Failure with Preserved Ejection Fraction Abstract  similar documents
Z. M. Akhilgova, I. I. Almazova, N. K. Gabitova, E. A. Kotaeva, A. G. Avtandilov
"... stiffness and endothelial function in patients with heart failure with preserved ejection fraction (HFpEF ..."
 
Vol 3, No 5 (2007) FEMALE SEX HORMONES AS MODULATORS OF GENDER DIFFERENCES IN RESPONSE TO PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, E. S. Krasilnikova, E. E. Kazantseva
"... prevention of cardiovascular diseases is reviewed. The results of retrospective and plaсebo-controlled trials ..."
 
Vol 18, No 5 (2022) A New Chapter in the Treatment of Patients with Heart Failure. The Role of Sodium-Glucose Co-transporter Type 2 Inhibitors Abstract  similar documents
D. P. Golubovskaya, V. N. Karetnikova, I. R. Oleinik, O. L. Barbarash
"... Хроническая сердечная недостаточность (ХСН) остается одной из серьезных социальных и медицинских ..."
 
Vol 20, No 2 (2024) Long-term effects of enhanced external counterpulsation in the management of patients with ischemic chronic heart failure Abstract  similar documents
A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, M. F. Petruhnova, E. V. Privalova, Yu. N. Belenkov
"... counterpulsation (EECP) in patients with stable coronary artery disease (CAD) complicated by chronic heart failure ..."
 
Vol 20, No 1 (2024) Effectiveness of different treatment regimens of enhanced external counterpulsation in patients with stable coronary artery disease complicated by heart failure Abstract  similar documents
A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov
"... in patients with stable coronary artery disease (CAD) complicated by chronic heart failure (CHF). Material ..."
 
Vol 17, No 5 (2021) Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers Abstract  similar documents
V. N. Larina, M. V. Leonova
"... недостаточности (ХСН), аритмий сердца, значимо улучшая прогноз пациентов. Вместе с тем клиническая эффективность ..."
 
Vol 18, No 2 (2022) Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases Abstract  similar documents
A. N. Zakirova, N. E. Zakirova
"... of atheromatous plaque. Wide-scale clinical trials have established high efficacy of ω-3 PUFA in primary ..."
 
Vol 9, No 6 (2013) THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) Abstract  similar documents
V. A. Sulimov
"... , застойную сердечную недостаточность, или повторный инфаркт, возникшие в течение первых 30 дней наблюдения ..."
 
Vol 15, No 5 (2019) Efficacy, Safety and Long-term Outcomes of Nicorandil Use in Patients with Stable Ischemic Heart Disease According to the Results of Randomized and Observational Studies Abstract  similar documents
Yu. V. Lukina, N. P. Kutishenko, S. Yu. Martsevich
"... декомпенсации хронической сердечной недостаточности, фибрилляции предсердий, нестабильной стенокардии напряжения ..."
 
Vol 7, No 1 (2011) ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT? Abstract  similar documents
L. N. Malay
"... , сердечной недостаточности, госпитализаций по сердечно-сосудистой причине). Представлены результаты таких ..."
 
Vol 10, No 6 (2014) «MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION Abstract  similar documents
S. R. Gilyarevskiy
"... в исследовании INVEST. При лечении больных АГ и ИБС в отсутствие сердечной недостаточности/систолической ..."
 
Vol 7, No 3 (2011) TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR Abstract  similar documents
I. M. Sokolov
"... (ИМ) в анамнезе; стенокардии у лиц с ИМ в анамнезе без признаков систолической сердечной недостаточности ..."
 
Vol 22, No 1 (2026) Sodium-glucose cotransporter 2 inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis Abstract  similar documents
Yu. A. Vyalkina, E. M. Mezhonov, Z. M. Safiullina, K. S. Kozlova, S. V. Shalaev
"... -0,81, p=0,006) и на 32% реже возникали госпитализации по причине сердечной недостаточности ..."
 
Vol 14, No 4 (2018) Takotsubo Syndrome: Contemporary Views on the Pathogenesis, Prevalence and Prognosis Abstract  similar documents
A. S. Shilova, A. O. Shmotkina, A. A. Yafarova, M. Yu. Gilyarov
"... недостаточности, а госпитальная летальность сопоставима с таковой при инфаркте миокарда с подъемом сегмента ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... (81,6%), треть имели в анамнезе инфаркт миокарда, более половины имели сердечную недостаточность (59,8 ..."
 
Vol 21, No 1 (2025) The no-reflow phenomenon: current treatment and prevention strategies Abstract  similar documents
S. V. Dil, E. V. Vyshlov, M. A. Kercheva, L. N. Maslov, V. V. Ryabov
"... кровотока, значительно ухудшает клинические исходы, повышая риск сердечной недостаточности и смерти ..."
 
Vol 21, No 6 (2025) Safety of using the intravenous beta-1-adrenoblocker esmolol in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention Abstract  similar documents
O. A. Saygina, T. S. Sukhinina, M. A. Terenicheva, O. V. Stukalova, M. G. Chashchin, D. V. Pevsner
"... сердечной недостаточности (ОСН), гипотонии, брадикардии, нарушений атриовентрикулярной проводимости ..."
 
1 - 32 of 32 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)